Understanding the structural requirements of triarylethane analogues towards PDE-IV inhibitors: A molecular modeling study

Indian Journal of Chemistry - Section A Inorganic, Physical, Theoretical and Analytical Chemistry

Volumn 45, Issue 1, 2006, Pages 68-76

  Srivani, P ^a   Kiran, K ^a   Sastry, G Narahari ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645377752     PISSN: 03764710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Qing H, Wang H, Sun Y, Kim H Y, Liu Y & Ke H, Structure, 11 (2003) 865.
2. Xu R X, Rocque W J, Lambert M H, Vanderwall D E, Luther M A & Nolte R T. J Mol Biol, 337 (2004) 355.
3. Lee M E, Markowitz J, Lee J O & Lee H, FEBS Letters, 530 (2002) 53.
4. Huai Q, Colicelli J & Ke H, Biochemistry, 42 (2003) 13220.
5. Torphy T J, Livi G P & Christensen S B, DN&P, 6 (1993) 203.
6. Rocque J W, Tian G, Wiseman S J, Holmes D W, Thomson Z I, Willard H D, Patel R I, Wisely B G, Clay C W, Kadwell H S, Hoffmann R C & Luther A M, Biochemistry, 36 (1997) 14250
7. Huang Z, Ducharme Y, Macdonald D & Rohichaud A, Curr Opin Chem Biol, 5 (2001) 432.
8. Alexander R P, Warrellow G J, Eaton M A W, Boyd E C, Head J C, Porter J R, Brown J A, Reuberson J T, Hutchinson B, Turner P, Boyce B, Barnes D, Mason B, Cannell A, Taylor R J, Zomaya A, Millican A, Leonard J, Morphy R, Wales M, Perry M, Allen R A, Gozzard N, Hughes B & Higgs G, Bioorg Med Chem Lett. 12 (2002) 1451.
9. Palfreyman M N. Drugs Fut, 20 (1995) 793.
10. Barton B E, Drugs Fut, 23 (1998) 517.
11. Fossa P, Menizzi G & Mosti L, QSAR. 20 (2001) 17.
12. Cramer R D, Patterson D E & Bunce J D, J Am Chem Soc., 110 (1988) 5959.
13. SYBYL 65 Tripos Associates Inc. USA.
14. GOLD 21 Cambridge Crystallographic Data Center. Cambridge, UK.
15. Jones G, Willet P, Glen R C, Leach A R & Taylor R, J Mol Biol, 267 (1997) 727.
16. Rarey M, Kramer B, Lengauer T & Klebe G, J Mol Biol, 261 (1996) 470.
17. AutoDock 10550 North Torrey Pines Road La Jolla CA 92037-1000 U.S.A.
18. Hu X, Balaz S & Shelver W H, J Mol Graph Model, 22 (2004) 293.
19. Compound 1 being a mixture of compound 15 and 16 could not be included in the models.
20. Guay D, Hamel P, Blouin M, Brideau C, Chan C C, Chauret N, Ducharme Y, Huang Z, Girard M, Jones R T, Laliberte F, Masson P, McAuliffe M, Piechuta H, Silva J, Young N R & Girard Y, Bioorg Med Chem Lett, 12 (2002) 1457.
21. (b) Frenette R, Blouin M, Brideau C, Chauret N, Ducharme Y, Friesen W R, Hamel P, Jones R T, Laliberte F, Li C, Masson P, McAuliffe M & Girard Y, Bioorg Med Chem Lett, 12 (2002) 3009.
22. (c) Ducharme Y, Friesen W R, Blouin M, Cote B, Dube D, Ethier D, Frenette R, Laliberte F, Mancini A J, Masson P, Styhler A, Young N R & Girard Y, Bioorg Med Chem Lett, 13 (2003) 1923.
23. Dym O, Xenarios I, Ke H & Colicelli J, Mol Pharmacol, 61 (2002) 20.
24. Chakraborti A K, Gopalakrishnan B, Sobhia M E & Malde A, Bioorg Med Chem Lett, 13 (2003) 1403.
25. Purushottamachar P & Kulkarni M V, Bioorg Med Chem, 11 (2003) 3487.
26. Bernard P, Pintore M, Berthon J Y & Chretien J R, Eur J Med Chem, 36 (2001) 1.
27. Chakraborti A K & Thilagavathi R, Bioorg Med Chem, 11 (2003) 3989.
28. Liu X, Yang Z & Wang L, Chemosphere, 53 (2003) 945.
29. Gopalakrishnan B, Khandelwal A, Rajjak S A, Selvakumar N, Das J, Trehan S, Iqbal J & Kumar M S, Bioorg Med Chem, 11 (2003) 2569.
30. Kim H J, Chae C H, Yi K Y, Park K L & Yoo S, Bioorg Med Chem, 12 (2004) 1629.
31. Huang M, Yang D Y, Shang Z, Zou J & Yu Q, Bioorg Med Chem Lett, 12 (2002) 2271.